Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Exelixis, Inc. - Common Stock (NQ:EXEL)

37.42 -0.48 (-1.27%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Exelixis, Inc. - Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
19 20 Next >
Exelixis Announces First Quarter 2023 Financial Results and Provides Corporate Update
From Exelixis, Inc.
Via Business Wire
Amid Proxy Challenge From Farallon, Exelixis' Board Member Resigns
Exelixis Inc's (NASDAQ: EXEL) board member Lance Willsey announced his resignation from the Board,  
Via Benzinga
Farallon Capital Management Comments on Successful Campaign for Change at Exelixis
From Farallon Capital Management L.L.C.
Via Business Wire
Exelixis Announces Departure of Lance Willsey, M.D. From Board of Directors
From Exelixis, Inc.
Via Business Wire
What 9 Analyst Ratings Have To Say About Exelixis
 
Via Benzinga
Why Exelixis Stock Leaped More Than 4% Higher Today
Oh, how some investors love stock buyback programs. 
Via The Motley Fool
Analyst Ratings for Exelixis
 
Via Benzinga
Exelixis to Present at the BofA Securities 2023 Healthcare Conference on May 10, 2023
From Exelixis, Inc.
Via Business Wire
Farallon Capital Urges Exelixis Shareholders to Support Change by Electing Its Three Highly Qualified Director Candidates
From Farallon Capital Management L.L.C.
Via Business Wire
Exelixis Files Definitive Proxy Statement and Mails Letter to Shareholders
From Exelixis, Inc.
Via Business Wire
2 Stocks to Buy With Less Than $20
Some relatively low-priced shares can be good buys, too. 
Via The Motley Fool
The Latest Analyst Ratings for Exelixis
 
Via Benzinga
Exelixis to Release First Quarter 2023 Financial Results on Tuesday, May 9, 2023
From Exelixis, Inc.
Via Business Wire
The Smartest Stocks to Buy With $20 Right Now and Hold Forever
These cheap stocks have the potential to skyrocket over the long haul. 
Via The Motley Fool
Nasdaq Bear Market: 5 Sensational Growth Stocks You'll Regret Not Buying on the Dip
Opportunistic investors would be wise to pounce on innovative growth stocks following a 33% decline in the Nasdaq Composite. 
Via The Motley Fool
Exelixis Advances Board Refreshment Plan
From Exelixis, Inc.
Via Business Wire
Exelixis Reiterates Commitment to Shareholder Value Creation
From Exelixis, Inc.
Via Business Wire
2 Under-the-Radar Biotech Stocks to Buy in 2023
Both companies have game-changing product portfolios that should result in stock price growth. 
Via The Motley Fool
Facebook Turns To Generative AI For Help, FedEx Consolidates, UBS Executives Say Surprise Credit Suisse Deal 'Major Challenge:' Today's Top Stories
Benzinga 
Via Benzinga
Farallon Capital Might Undertake Proxy Fight Against Exelixis, Nominates Three Directors
 
Via Benzinga
Farallon Issues Letter to Exelixis Board of Directors Outlining Case for Change
From Farallon Capital Management L.L.C.
Via Business Wire
2 Incredible Stocks to Buy With Less Than $25
Nothing beats a great investment for the price of just a few cups of coffee. 
Via The Motley Fool
Exelixis Stock Shows Rising Relative Price Performance; Still Shy Of Key Benchmark
In a welcome move, Exelixis stock saw its Relative Strength Rating improve to 73 on Monday, up from 69 a day earlier. 
Via Investor's Business Daily
Exelixis Announces $550 Million Share Repurchase Program
From Exelixis, Inc.
Via Business Wire
3 Beaten-Down Stocks That Could Soar This Year
These stocks could enjoy big rebounds in 2023. 
Via The Motley Fool
Exelixis Stock Generating Improved Relative Strength Rating
Exelixis stock saw a welcome improvement to its Relative Strength (RS) Rating on Thursday, with an upgrade from 69 to 76. 
Via Investor's Business Daily
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy. 
Via InvestorPlace
Exelixis to Webcast Fireside Chat at the 2023 Guggenheim Healthy Altitudes Summit
From Exelixis, Inc.
Via Business Wire
Nasdaq Bear Market: 5 Stunning Growth Stocks You'll Regret Not Buying on the Dip
A 33% plunge in the previously high-flying Nasdaq Composite is the perfect time for growth investors to pounce on some amazing deals. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For March 9, 2023
 
Via Benzinga
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback